EUVIMEDEUVIMED entdecken
Open Access

Histone deacetylase 3‑mediated histone deacetylation combined with activating transcription factor 3 promotes renal fibrosis by inhibiting Klotho

Zhiying Yang, Xueling Wang, Wenhong Li, Hao Chen, Gang Liu

Molecular Medicine Reports · 2026

DOI: 10.3892/mmr.2026.13985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Medicine Reports, 2026. Verfasst von Zhiying Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan 650051, P.R. China. Hauptthemen laut MEDLINE: Histone Deacetylases, Glucuronidase, Activating Transcription Factor 3, Histones. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal fibrosis is a representative pathological trait of renal aging and chronic kidney disease. However, the regulatory mechanisms of histone deacetylation in renal fibrosis remain unclear. A mouse renal fibrosis model was constructed using the unilateral ureteric obstruction method, and HK2 cells treated with TGF‑β were used to create a renal fibrosis cell model. Low expression of Klotho in renal fibrosis is associated with histone deacetylase 3 (HDAC3)‑mediated histone deacetylation. After TGF‑β treatment, H3K9ac and Klotho binding was markedly decreased, while H3K9ac was enriched in the Klotho group after the addition of the HDAC3 inhibitor. Further experiments demonstrated that HDAC3 binding activates transcription factor 3, inhibits Klotho transcription and promotes cellular renal fibrosis. The absence of Klotho may activate the Wnt/β‑catenin and NF‑κB pathways to promote oxidative stress and inflammation, thereby exacerbating the fibrotic process. HDAC3 binds to ATF3 to transcriptionally repress Klotho, leading to activation of the Wnt/β‑catenin and NF‑κB pathways and exacerbation of renal fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone DeacetylasesGlucuronidaseActivating Transcription Factor 3HistonesKidney DiseasesKidneyAnimalsHistone Deacetylase 3Klotho ProteinsFibrosisMiceHumansAcetylationWnt Signaling PathwayNF-kappa BMaleCell LineTransforming Growth Factor beta

Stichwörter der Autor:innen

KlothoNF-κBWnt/β‑cateninactivating transcription factor 3histone deacetylase 3renal fibrosis

Substanzen

Histone DeacetylasesHistone Deacetylase 3Klotho ProteinsGlucuronidaseActivating Transcription Factor 3HistonesNF-kappa BAtf3 protein, mouseTransforming Growth Factor betaKL protein, human

Autor:innen und Institutionen

  • Department of Nephrology, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan 650051, P.R. China.
  • Department of Nephrology, The Second Qilu Hospital of Shandong University, Jinan, Shandong 250033, P.R. China.

Zitieren

APA

Yang, Z., Wang, X., Li, W., Chen, H., & Liu, G. (2026). Histone deacetylase 3‑mediated histone deacetylation combined with activating transcription factor 3 promotes renal fibrosis by inhibiting Klotho. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2026.13985

Vancouver

Yang Z, Wang X, Li W, Chen H, Liu G. Histone deacetylase 3‑mediated histone deacetylation combined with activating transcription factor 3 promotes renal fibrosis by inhibiting Klotho. Molecular Medicine Reports. 2026. doi:10.3892/mmr.2026.13985

BibTeX
@article{Yang2026,
  author = {Yang, Zhiying and Wang, Xueling and Li, Wenhong and Chen, Hao and Liu, Gang},
  title = {Histone deacetylase 3‑mediated histone deacetylation combined with activating transcription factor 3 promotes renal fibrosis by inhibiting Klotho},
  journal = {Molecular Medicine Reports},
  year = {2026},
  doi = {10.3892/mmr.2026.13985}
}
Kostenlos starten →